78 related articles for article (PubMed ID: 21277347)
1. Exciting times for our field and the Journal.
Humphries RK
Exp Hematol; 2011 Mar; 39(3):271. PubMed ID: 21277347
[No Abstract] [Full Text] [Related]
2. Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia.
Koldehoff M; Steckel NK; Beelen DW; Elmaagacli AH
Clin Exp Med; 2006 Mar; 6(1):45-7. PubMed ID: 16550344
[No Abstract] [Full Text] [Related]
3. [Pathophysiology and treatment of acute myeloid leukemia].
Naoe J
Rinsho Ketsueki; 2003 Apr; 44(4):219-26. PubMed ID: 12784654
[No Abstract] [Full Text] [Related]
4. Chronic myeloid leukemia: proving ground for cancer stem cells.
Daley GQ
Cell; 2004 Oct; 119(3):314-6. PubMed ID: 15507204
[TBL] [Abstract][Full Text] [Related]
5. Association of KIR2DS4 and its variant KIR1D with leukemia.
Giebel S; Nowak I; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Kyrcz-Krzemien S; Kusnierczyk P
Leukemia; 2008 Nov; 22(11):2129-30; discussion 2130-1. PubMed ID: 18463675
[No Abstract] [Full Text] [Related]
6. The growth factor independence-1 (Gfi1) is overexpressed in chronic myelogenous leukemia.
Huang M; Hu Z; Chang W; Ou D; Zhou J; Zhang Y
Acta Haematol; 2010; 123(1):1-5. PubMed ID: 19887785
[TBL] [Abstract][Full Text] [Related]
7. N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia.
Lopotová T; Nádvorníková S; Záčková M; Polák J; Schwarz J; Klamová H; Moravcová J
Leuk Res; 2012 Apr; 36(4):e81-3. PubMed ID: 22226711
[No Abstract] [Full Text] [Related]
8. Leukemic colony formation from patients with acute leukemia: evidence of the identity in karyotype of the colonies from patients with cytogenetic abnormalities.
Ishibashi T
Fukushima J Med Sci; 1987 Dec; 33(2):71-83. PubMed ID: 3509037
[No Abstract] [Full Text] [Related]
9. [Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons].
Cazzola M; Pedrazzoli P; Bergamaschi G; Buonanno C; Cuomo A; D'Uva R; Ponchio L; Rosti V; Zappone E; Ascari E
Haematologica; 1990; 75 Suppl 4():20-7. PubMed ID: 2127411
[No Abstract] [Full Text] [Related]
10. Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia.
Pieroni F; Oliveira FM; Panepucci RA; Voltarelli JC; Simões BP; Falcão RP
Bone Marrow Transplant; 2006 Apr; 37(8):801-2. PubMed ID: 16501585
[No Abstract] [Full Text] [Related]
11. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
[TBL] [Abstract][Full Text] [Related]
12. Autologous blood stem cell transplantation.
Goldman JM
Beitr Infusionsther; 1988; 21():317-21. PubMed ID: 2463002
[No Abstract] [Full Text] [Related]
13. Chronic versus acute myelogenous leukemia: a question of self-renewal.
Jamieson CH; Weissman IL; Passegué E
Cancer Cell; 2004 Dec; 6(6):531-3. PubMed ID: 15607956
[TBL] [Abstract][Full Text] [Related]
14. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
15. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
16. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
Schulze E; Krahl R; Thalmeier K; Helbig W
Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
[TBL] [Abstract][Full Text] [Related]
17. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.
Ruan GR; Qin YZ; Chen SS; Li JL; Ma X; Chang Y; Wang YZ; Fu JY; Liu YR
Leuk Res; 2006 Sep; 30(9):1159-65. PubMed ID: 16507320
[TBL] [Abstract][Full Text] [Related]
19. [Chronic myeloid leukemia as a model for the development and therapeutic use of tyrosine kinase inhibitors].
López-Karpovitch X
Rev Invest Clin; 2003; 55(2):191-5. PubMed ID: 12827926
[No Abstract] [Full Text] [Related]
20. Recent advancements in the treatment of chronic myelogenous leukemia.
O'Dwyer ME; Mauro MJ; Druker BJ
Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]